Higher CD3(+) and CD34(+) cell doses in the graft increase the incidence of acute GVHD in children receiving BMT for thalassemia.
Gaziev J, Isgrò A, Marziali M, Daniele N, Gallucci C, Sodani P, Simone MD, Adorno G, Paciaroni K, Andreani M, Lanti A, Del Proposto G, Testi M, De Angelis G, Roveda A, Alfieri C, Saltarelli F, Lucarelli G.
Gaziev J, et al. Among authors: andreani m.
Bone Marrow Transplant. 2012 Jan;47(1):107-14. doi: 10.1038/bmt.2011.3. Epub 2011 Feb 14.
Bone Marrow Transplant. 2012.
PMID: 21317935
Clinical Trial.